TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
109
|
123
|
116 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
47
|
67
|
33 |
| EBITDA |
44
|
64
|
32 |
| Total assets |
213
|
200
|
197 |
| Current assets |
213
|
200
|
197 |
| Current liabilities |
2
|
2
|
1 |
| Equity capital |
206
|
193
|
190 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.7%
|
96.5%
|
96.4% |
| Turnover per employee |
109
|
123
|
116 |
| Profit as a percentage of turnover |
43.1%
|
54.5%
|
28.4% |
| Return on assets (ROA) |
22.1%
|
33.5%
|
16.8% |
| Current ratio |
10650.0%
|
10000%
|
19700% |
| Return on equity (ROE) |
22.8%
|
34.7%
|
17.4% |
| Change turnover |
-10
|
7
|
0 |
| Change turnover % |
-8%
|
6%
|
0% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.